Close Menu

NEW YORK — Biodesix said Wednesday it has entered a regulatory cooperation agreement with lab equipment firm Streck that will allow it to incorporate Streck's blood collection tubes (BCTs) into its sample collection protocols.

Biodesix said that the agreement will aid its efforts to win US Food and Drug Administration approval for lung cancer companion diagnostics using next-generation sequencing and droplet digital PCR.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Oct
27
Sponsored by
LGC SeraCare Life Sciences

This webinar brings together an expert panel of stakeholders in cancer diagnostics and clinical care who will discuss the promise and challenges of liquid biopsy technologies in cancer diagnosis, monitoring, and patient care management.